Jiangmen Central Hospital
Clinical trials sponsored by Jiangmen Central Hospital, explained in plain language.
-
Promising new combo for tough lung cancer: Low-Dose radiation plus immunotherapy
Disease control Not yet recruitingThis study tests a new treatment for people with extensive-stage small cell lung cancer, a fast-growing cancer that has spread. It combines low-dose radiation to the chest with an immunotherapy drug (adebrelimab) and chemotherapy, followed by maintenance immunotherapy for up to t…
Phase: PHASE2 • Sponsor: Jiangmen Central Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
New combo therapy aims to control lung cancer spread in the chest
Disease control Not yet recruitingThis study is for people with a specific type of lung cancer (EGFR-positive adenocarcinoma) that has spread to the lining of the chest, causing fluid buildup. Researchers are testing whether combining a daily targeted pill (furmonertinib) with focused chest radiation can safely c…
Phase: PHASE2 • Sponsor: Jiangmen Central Hospital • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC